BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1382 related articles for article (PubMed ID: 7577367)

  • 1. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
    Stein B; Baldwin AS
    Mol Cell Biol; 1993 Nov; 13(11):7191-8. PubMed ID: 8413306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NF kappa B-like transcription factors.
    Li XX; Liao WS
    J Biol Chem; 1991 Aug; 266(23):15192-201. PubMed ID: 1869549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
    Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
    J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
    Merola M; Blanchard B; Tovey MG
    J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
    Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
    J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
    Jenkins F; Cockerill PN; Bohmann D; Shannon MF
    J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerted participation of NF-kappa B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver.
    Ray A; Hannink M; Ray BK
    J Biol Chem; 1995 Mar; 270(13):7365-74. PubMed ID: 7706280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of HIV-1 gene expression by NF-IL6.
    Tesmer VM; Bina M
    J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.
    Ross HL; Gartner S; McArthur JC; Corboy JR; McAllister JJ; Millhouse S; Wigdahl B
    J Neurovirol; 2001 Jun; 7(3):235-49. PubMed ID: 11517398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
    Galien R; Evans HF; Garcia T
    Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors.
    Legraverend C; Antonson P; Flodby P; Xanthopoulos KG
    Nucleic Acids Res; 1993 Apr; 21(8):1735-42. PubMed ID: 8493090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
    Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
    EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
    Smith CD; Baglia LA; Curristin SM; Ruddell A
    J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
    Gaynor RB; Kuwabara MD; Wu FK; Garcia JA; Harrich D; Briskin M; Wall R; Sigman DS
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5'-monophosphate response element binding protein.
    Dumais N; Bounou S; Olivier M; Tremblay MJ
    J Immunol; 2002 Jan; 168(1):274-82. PubMed ID: 11751971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.